cytidine triphosphate has been researched along with Esophageal Neoplasms in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Dong, Z; Guo, W; Guo, X; Guo, Y; Kuang, G; Shen, S; Wang, C | 1 |
Abraham, JM; Agarwal, R; Beer, D; Cheng, Y; David, S; Hamilton, JP; Ito, T; Jin, Z; Kan, T; Meltzer, SJ; Montgomery, E; Mori, Y; Olaru, A; Paun, B; Sato, F; Yang, J | 1 |
2 other study(ies) available for cytidine triphosphate and Esophageal Neoplasms
Article | Year |
---|---|
RASSF5A, a candidate tumor suppressor, is epigenetically inactivated in esophageal squamous cell carcinoma.
Topics: Adaptor Proteins, Signal Transducing; Adult; Aged; Alternative Splicing; Apoptosis; Apoptosis Regulatory Proteins; Azacitidine; Biomarkers, Tumor; Carcinoma, Squamous Cell; Cell Line, Tumor; Cell Proliferation; Cytidine Triphosphate; DNA Methylation; Esophageal Neoplasms; Esophagus; Female; Genes, Tumor Suppressor; Genetic Predisposition to Disease; Humans; Hydroxamic Acids; Male; Middle Aged; Monomeric GTP-Binding Proteins; Neoplasm Invasiveness; Prognosis; Promoter Regions, Genetic; Protein Isoforms; Protein Synthesis Inhibitors; RNA, Messenger, Stored | 2015 |
Hypermethylation of the nel-like 1 gene is a common and early event and is associated with poor prognosis in early-stage esophageal adenocarcinoma.
Topics: Aged; Azacitidine; Calcium-Binding Proteins; Cell Line, Tumor; Cytidine Triphosphate; DNA Methylation; Esophageal Neoplasms; Humans; Middle Aged; Neoplasm Staging; Nerve Tissue Proteins; Prognosis; Promoter Regions, Genetic; RNA, Messenger; Survival Rate; Time Factors | 2007 |